explore -WSS

explore

author：hotspot 2025-09-29 18:18:04 - browse：3138

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Microbiome research is starting to find links to chronic diseases

WSS

Congress needs to close a vaccine

Anthony Fauci pushes back on GOP claims during Covid hearing

CDC advisers recommend seasonal use of Pfizer RSV shot

Structure Therapeutics oral GLP

Readout LOUD podcast: possible new ALS drug, artificial wombs

Anthony Fauci pushes back on GOP claims during Covid hearing

Wikipedia

explore

explore

ChatGPT in medicine: STAT answers readers' burning questions

CDC's new outbreak response network to include Northeastern

Peter Hotez and the public health issue of online harassment

Illumina board agrees to spin off Grail, as divestment plans proceed

Jerome Adams on the need for new antivirals for Covid

FDA approves Moderna’s RSV vaccine, its second licensed product

At least 13 dead in Texas as scorching temps continue

How AI helped researchers track recovery from depression

Medical leaders decry Supreme Court decision on affirmative action

Lasker Awards 2023: Winners in biomedical research

hotspot

Elevance PBM president out as customers face prescription chaos

Microbiome research is starting to find links to chronic diseases

CMS got Medicare Advantage quality rating wrong, judge rules

Eli Lilly’s Zepbound improved liver scarring in mid

ASCO Daily Recap: CAR

Second xenotransplant done with gene

hotspot

Wikipedia

explore

leisure time